日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting Wnt/β-catenin signaling enhances the efficacy of anti-CD38 immunotherapy in multiple myeloma

靶向Wnt/β-catenin信号通路可增强抗CD38免疫疗法在多发性骨髓瘤中的疗效

Li, Heng; Chen, Yunguang; Gregorova, Michaela; Yang, Tingting; Zhang, Xiayi; Yu, Xiaoyu; Wang, Zhen; Hua, Haiying; Ye, Long; Qi, Xiaowei; Spaargaren, Marcel; Pals, Steven T; Ren, Zemin

Presentation of CXCL12γ by heparan sulfate proteoglycans activates CXCR4 without desensitization in normal and malignant B cells.

硫酸乙酰肝素蛋白聚糖呈递 CXCL12α 可激活正常和恶性 B 细胞中的 CXCR4,而不会发生脱敏

Lantermans Hildo C, Ma Fangxue, Kuil Annemieke, de Rooij Martin F M, Bergkamp Nick D, van der Meer Werner, van Buul Jaap D, Smit Martine J, Kersten Marie José, Spaargaren Marcel, Pals Steven T

Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.

鼻窦弥漫性大B细胞淋巴瘤:分子谱分析可识别具有独特预后和可靶向遗传特征的亚型

Eriksen Patrick R G, de Groot Fleur, Clasen-Linde Erik, de Nully Brown Peter, de Groen Ruben, Melchior Linea C, Maier Andrea D, Minderman Marthe, Vermaat Joost S P, von Buchwald Christian, Pals Steven T, Heegaard Steffen

Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study

伊沙佐米联合皮下注射利妥昔单抗和地塞米松治疗复发或难治性华氏巨球蛋白血症:I/II期HOVON124/ECWM-R2研究的最终分析

Kersten, Marie José; Amaador, Karima; Minnema, Monique C; Vos, Josephine M I; Nasserinejad, Kazem; Kap, Marcel; Kastritis, Efstathios; Gavriatopoulou, Maria; Kraan, Willem; Chamuleau, Martine E D; Deeren, Dries; Tick, Lidwine W; Doorduijn, Jeanette K; Offner, Fritz; Böhmer, Lara H; Liu, Roberto D; Pals, Steven T; Dimopoulos, Meletios A

Megalobastic anemia, infantile leukemia, and immunodeficiency caused by a novel homozygous mutation in the DHFR gene

巨叶性贫血、婴儿白血病和免疫缺陷是由DHFR基因中一种新的纯合突变引起的。

Kuijpers, Taco W; de Vries, Andrica C H; van Leeuwen, Ester M; Ermens, A Ton A M; de Pont, Saskia; Smith, Desirée E C; Wamelink, Mirjam M C; Mensenkamp, Arjen R; Nelen, Marcel R; Lango Allen, Hana; Pals, Steven T; Beverloo, Berna H B; Huidekoper, Hidde H; Wagner, Anja

The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma

CXCL12γ趋化因子被硫酸乙酰肝素固定在基质细胞上,从而控制细胞黏附并介导多发性骨髓瘤的耐药性。

Ren, Zemin; Lantermans, Hildo; Kuil, Annemieke; Kraan, Willem; Arenzana-Seisdedos, Fernando; Kersten, Marie José; Spaargaren, Marcel; Pals, Steven T

Correction to: The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma

更正:CXCL12γ趋化因子被硫酸乙酰肝素固定在基质细胞上,从而控制细胞黏附并介导多发性骨髓瘤的耐药性。

Ren, Zemin; Lantermans, Hildo; Kuil, Annemieke; Kraan, Willem; Arenzana-Seisdedos, Fernando; Kersten, Marie José; Spaargaren, Marcel; Pals, Steven T

Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation

与携带相同致癌突变的多种血液系统恶性肿瘤相关的组织细胞肿瘤谱

Kemps, Paul G; Hebeda, Konnie M; Pals, Steven T; Verdijk, Robert M; Lam, King H; Bruggink, Annette H; de Lil, Heleen S; Ruiterkamp, Bart; de Heer, Koen; van Laar, Jan Am; Valk, Peter Jm; Mutsaers, Pim; Levin, Mark-David; Hogendoorn, Pancras Cw; van Halteren, Astrid Gs

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis

MYD88 突变可识别出弥漫性大 B 细胞淋巴瘤的一个分子亚型,该亚型预后不良。

Vermaat, Joost S; Somers, Sebastiaan F; de Wreede, Liesbeth C; Kraan, Willem; de Groen, Ruben A L; Schrader, Anne M R; Kerver, Emile D; Scheepstra, Cornelis G; Berenschot, Henriëtte; Deenik, Wendy; Wegman, Jurgen; Broers, Rianne; de Boer, Jan-Paul D; Nijland, Marcel; van Wezel, Tom; Veelken, Hendrik; Spaargaren, Marcel; Cleven, Arjen H; Kersten, Marie José; Pals, Steven T

Towards genomic-based prognostication and precision therapy for diffuse large B-cell lymphoma

迈向基于基因组的弥漫性大B细胞淋巴瘤预后预测和精准治疗

Minderman, Marthe; Pals, Steven T